Moderate hypofractionated helical tomotherapy for older patients with localized prostate cancer: long-term outcomes of a phase I–II trial
Our previous study showed that two different regimens of moderate hypofractionated radiotherapy (HFRT) delivered with helical tomotherapy (HT) are well tolerated in older prostate cancer patients. We provide a longterm efficacy and toxicity after > 7 years of follow-up.
Main Authors: | Cui Di, Du Lei, Yu Wei, Cai Boning, Meng Lingling, Yang Jun, Luo Yanrong, Chen Jing, Ma Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2022-03-01
|
Series: | Radiology and Oncology |
Subjects: | |
Online Access: | https://doi.org/10.2478/raon-2022-0011 |
Similar Items
-
Long-term outcomes of nasopharyngeal carcinoma treated with helical tomotherapy using simultaneous integrated boost technique: A 10-year result
by: Lingling Meng, et al.
Published: (2023-01-01) -
The outcome of the first 100 nasopharyngeal cancer patients in thailand treated by helical tomotherapy
by: Chitapanarux Imjai, et al.
Published: (2017-04-01) -
Hypofractionated whole breast irradiation with simultaneous integrated boost in breast cancer using helical tomotherapy with or without regional nodal irradiation: A report of acute toxicities
by: Imjai Chitapanarux, et al.
Published: (2023-03-01) -
Fractionated Stereotactic Radiotherapy with Helical Tomotherapy for Brain Metastases: A Mono-Institutional Experience
by: Francesco Cuccia, et al.
Published: (2023-07-01) -
Helical versus static approaches to delivering tomotherapy to the junctional target for patients taller than 135 cm undergoing total body irradiation
by: Mümtaz Köksal, et al.
Published: (2022-11-01)